Truist Financial Corp Novartis Ag Transaction History

Truist Financial Corp

  • $62.7 Billion
  • Q4 2024

A detailed history of Truist Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Truist Financial Corp holds 771,655 shares of NVS stock, worth $86.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
771,655
Previous 744,563 3.64%
Holding current value
$86.3 Million
Previous $85.6 Million 12.32%
% of portfolio
0.12%
Previous 0.14%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
BUY
$96.78 - $117.18 $2.62 Million - $3.17 Million
27,092 Added 3.64%
771,655 $75.1 Million
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $620,011 - $706,239
-5,842 Reduced 0.78%
744,563 $85.6 Million
Q2 2024

Aug 20, 2024
SELL
$92.57 - $107.37 $523,668 - $607,392
-5,657 Reduced 0.75%
750,405 $79.9 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $7.08 Million - $8.06 Million
-74,303 Reduced 8.95%
756,062 $73.1 Million
Q4 2023

Feb 02, 2024
SELL
$92.27 - $101.54 $3.09 Million - $3.4 Million
-33,494 Reduced 3.88%
830,365 $83.8 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $8.06 Million - $8.94 Million
85,075 Added 10.92%
863,859 $88 Million
Q2 2023

Aug 01, 2023
SELL
$92.52 - $104.91 $4.87 Million - $5.52 Million
-52,632 Reduced 6.33%
778,784 $78.6 Million
Q1 2023

May 05, 2023
SELL
$80.03 - $92.81 $9.95 Million - $11.5 Million
-124,363 Reduced 13.01%
831,416 $76.5 Million
Q4 2022

Feb 17, 2023
SELL
$75.55 - $92.52 $786,928 - $963,688
-10,416 Reduced 1.08%
955,779 $86.7 Million
Q3 2022

Oct 26, 2022
SELL
$74.61 - $87.26 $603,520 - $705,846
-8,089 Reduced 0.83%
966,195 $73.4 Million
Q2 2022

Jul 22, 2022
SELL
$80.52 - $93.75 $9.69 Million - $11.3 Million
-120,349 Reduced 10.99%
974,284 $82.4 Million
Q1 2022

Apr 22, 2022
BUY
$80.11 - $90.62 $6.11 Million - $6.91 Million
76,233 Added 7.49%
1,094,633 $96.1 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.34 Million - $1.49 Million
-16,861 Reduced 1.63%
1,018,400 $89.1 Million
Q3 2021

Nov 05, 2021
BUY
$81.78 - $95.14 $2.9 Million - $3.37 Million
35,423 Added 3.54%
1,035,261 $84.7 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $2.65 Million - $2.93 Million
31,103 Added 3.21%
999,838 $91.2 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $6.39 Million - $7.53 Million
76,499 Added 8.57%
968,735 $82.8 Million
Q4 2020

Feb 18, 2021
BUY
$78.07 - $94.43 $4.28 Million - $5.17 Million
54,765 Added 6.54%
892,236 $84.3 Million
Q3 2020

Nov 05, 2021
BUY
$82.14 - $91.0 $149,248 - $165,347
1,817 Added 0.22%
837,471 $72.8 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $402,650 - $446,082
4,902 Added 0.59%
835,654 $72.7 Million
Q2 2020

Nov 16, 2021
BUY
$80.93 - $91.1 $137,338 - $154,596
1,697 Added 0.2%
830,752 $72.6 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $2.06 Million - $2.32 Million
25,463 Added 3.17%
829,055 $72.4 Million
Q1 2020

Nov 05, 2021
BUY
$70.67 - $99.01 $119,926 - $168,019
1,697 Added 0.21%
803,592 $66.3 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $3.57 Million - $5 Million
50,467 Added 6.72%
801,895 $66.1 Million
Q4 2019

Nov 16, 2021
BUY
$84.35 - $95.37 $127,958 - $144,676
1,517 Added 0.2%
751,428 $71.2 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $50.9 Million - $57.5 Million
602,918 Added 410.17%
749,911 $71 Million
Q3 2019

Oct 31, 2019
SELL
$85.54 - $94.26 $326,420 - $359,696
-3,816 Reduced 2.53%
146,993 $12.8 Million
Q2 2019

Jul 24, 2019
SELL
$75.4 - $92.8 $518,450 - $638,092
-6,876 Reduced 4.36%
150,809 $13.8 Million
Q1 2019

Apr 23, 2019
SELL
$75.32 - $86.15 $881,243 - $1.01 Million
-11,700 Reduced 6.91%
157,685 $15.2 Million
Q4 2018

Jan 22, 2019
SELL
$73.66 - $82.02 $411,317 - $457,999
-5,584 Reduced 3.19%
169,385 $14.5 Million
Q3 2018

Oct 17, 2018
SELL
$66.94 - $77.43 $153,694 - $177,779
-2,296 Reduced 1.3%
174,969 $15.1 Million
Q2 2018

Jul 26, 2018
SELL
$64.91 - $73.36 $1.9 Million - $2.15 Million
-29,300 Reduced 14.18%
177,265 $13.4 Million
Q1 2018

Apr 20, 2018
SELL
$70.39 - $84.15 $2.34 Million - $2.8 Million
-33,261 Reduced 13.87%
206,565 $16.7 Million
Q4 2017

Jan 29, 2018
SELL
$72.33 - $77.64 $5.19 Million - $5.57 Million
-71,767 Reduced 23.03%
239,826 $20.1 Million
Q3 2017

Oct 23, 2017
BUY
$74.14 - $77.27 $23.1 Million - $24.1 Million
311,593
311,593 $26.8 Million

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email